Baker Bros. Advisors as of March 31, 2014
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 108 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Seattle Genetics | 12.0 | $945M | 21M | 45.56 | |
Synageva Biopharma | 11.2 | $884M | 11M | 82.97 | |
Pharmacyclics | 11.1 | $876M | 8.7M | 100.22 | |
Incyte Corporation (INCY) | 10.1 | $794M | 15M | 53.52 | |
ACADIA Pharmaceuticals (ACAD) | 6.3 | $498M | 21M | 24.33 | |
Salix Pharmaceuticals Inc note 2.750% 5/1 | 6.2 | $492M | 219M | 2.24 | |
Genomic Health | 4.6 | $360M | 14M | 26.34 | |
Incyte Corp Ltd conv | 4.5 | $351M | 275M | 1.28 | |
Incyte Corp Incy Cvt 144a 0.37 convert | 4.2 | $326M | 259M | 1.26 | |
Incyte Corp note 4.750%10/0 | 3.1 | $246M | 40M | 6.08 | |
InterMune | 1.8 | $145M | 4.3M | 33.47 | |
BioMarin Pharmaceutical (BMRN) | 1.6 | $129M | 1.9M | 68.21 | |
Auxilium Pharmaceuticals note | 1.6 | $128M | 98M | 1.31 | |
XOMA CORP Common equity shares | 1.5 | $120M | 23M | 5.21 | |
Itmn 2 1/2 12/15/17 | 1.4 | $108M | 41M | 2.63 | |
Intercept Pharmaceuticals In | 1.1 | $85M | 256k | 329.79 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.0 | $77M | 23M | 3.37 | |
Vanda Pharmaceuticals (VNDA) | 0.9 | $72M | 4.4M | 16.25 | |
Halozyme Therapeutics (HALO) | 0.9 | $72M | 5.7M | 12.70 | |
Gilead Sciences conv | 0.8 | $67M | 22M | 3.11 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $62M | 5.9M | 10.58 | |
Anacor Pharmaceuticals In | 0.8 | $62M | 3.1M | 20.01 | |
Medivation Inc note 2.625% 4/0 | 0.7 | $57M | 40M | 1.43 | |
Repros Therapeutics | 0.6 | $49M | 2.8M | 17.74 | |
Questcor Pharmaceuticals | 0.6 | $47M | 718k | 64.93 | |
Mirati Therapeutics | 0.6 | $45M | 2.4M | 19.07 | |
Derma Sciences | 0.6 | $45M | 3.5M | 12.68 | |
Cerus Corporation (CERS) | 0.5 | $41M | 8.5M | 4.80 | |
Gilead Sciences (GILD) | 0.5 | $39M | 556k | 70.86 | |
Acorda Therapeutics | 0.5 | $38M | 1.0M | 37.91 | |
Chelsea Therapeutics International | 0.5 | $37M | 6.8M | 5.52 | |
Clovis Oncology | 0.5 | $37M | 530k | 69.27 | |
Intermune cv 5.0% | 0.4 | $31M | 17M | 1.81 | |
Heron Therapeutics (HRTX) | 0.4 | $30M | 2.2M | 13.91 | |
Slxp 1 1/2 03/15/19 | 0.3 | $25M | 15M | 1.69 | |
Aegerion Pharmaceuticals | 0.3 | $24M | 514k | 46.12 | |
Dyax | 0.3 | $23M | 2.5M | 8.98 | |
XenoPort | 0.3 | $21M | 4.0M | 5.17 | |
AVANIR Pharmaceuticals | 0.3 | $21M | 5.8M | 3.67 | |
Progenics Pharmaceuticals | 0.2 | $18M | 4.4M | 4.09 | |
Aquinox Pharmaceuticals | 0.2 | $15M | 1.2M | 12.73 | |
Tg Therapeutics (TGTX) | 0.2 | $15M | 2.2M | 6.90 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.2 | $14M | 13M | 1.10 | |
Kythera Biopharmaceuticals I | 0.2 | $12M | 311k | 39.76 | |
Arrowhead Research | 0.1 | $12M | 732k | 16.42 | |
Tekmira Pharmaceuticals Corporation | 0.1 | $10M | 484k | 21.49 | |
Insmed (INSM) | 0.1 | $11M | 554k | 19.04 | |
Sangamo Biosciences (SGMO) | 0.1 | $9.5M | 523k | 18.08 | |
Omeros Corporation (OMER) | 0.1 | $9.1M | 754k | 12.07 | |
Synergy Pharmaceuticals | 0.1 | $9.3M | 1.8M | 5.31 | |
Qlt | 0.1 | $8.5M | 1.5M | 5.56 | |
Threshold Pharmaceuticals | 0.1 | $8.7M | 1.8M | 4.76 | |
Prothena (PRTA) | 0.1 | $8.8M | 230k | 38.31 | |
Discovery Laboratories | 0.1 | $7.9M | 3.7M | 2.15 | |
Galectin Therapeutics (GALT) | 0.1 | $7.7M | 500k | 15.31 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $7.8M | 200k | 39.15 | |
Array BioPharma | 0.1 | $6.7M | 1.4M | 4.70 | |
Neurocrine Biosciences (NBIX) | 0.1 | $7.2M | 448k | 16.10 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $7.4M | 624k | 11.89 | |
Zogenix | 0.1 | $6.7M | 2.4M | 2.85 | |
Biota Pharmaceuticals | 0.1 | $6.8M | 1.1M | 6.11 | |
D Stemline Therapeutics | 0.1 | $6.9M | 339k | 20.36 | |
Ambit Bioscience | 0.1 | $6.8M | 748k | 9.12 | |
Idera Pharmaceuticals | 0.1 | $6.6M | 1.6M | 4.08 | |
Aerie Pharmaceuticals | 0.1 | $6.3M | 299k | 21.19 | |
Xencor (XNCR) | 0.1 | $6.4M | 542k | 11.73 | |
Novavax | 0.1 | $5.5M | 1.2M | 4.53 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $5.5M | 446k | 12.32 | |
Osiris Therapeutics | 0.1 | $4.7M | 362k | 13.13 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $4.9M | 73k | 67.26 | |
Cytrx | 0.1 | $4.7M | 1.4M | 3.49 | |
Epizyme | 0.1 | $4.9M | 214k | 22.77 | |
Portola Pharmaceuticals | 0.1 | $4.7M | 183k | 25.90 | |
Bluebird Bio (BLUE) | 0.1 | $4.5M | 198k | 22.74 | |
Regado Biosciences | 0.1 | $5.0M | 400k | 12.52 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $4.9M | 100k | 48.89 | |
Ignyta | 0.1 | $4.7M | 571k | 8.30 | |
Celsus Therapeutics Plc sponsored adr ne | 0.1 | $4.4M | 674k | 6.49 | |
ISIS Pharmaceuticals | 0.1 | $4.2M | 96k | 43.21 | |
BioDelivery Sciences International | 0.1 | $3.6M | 421k | 8.44 | |
Retrophin | 0.1 | $4.2M | 197k | 21.27 | |
Furiex Pharmaceuticals | 0.0 | $3.5M | 40k | 87.00 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $3.2M | 81k | 39.98 | |
Synta Pharmaceuticals | 0.0 | $2.2M | 500k | 4.31 | |
Mast Therapeutics | 0.0 | $2.0M | 3.0M | 0.68 | |
Macrogenics (MGNX) | 0.0 | $2.7M | 96k | 27.83 | |
La Jolla Pharmaceuticl Com Par | 0.0 | $2.4M | 222k | 10.80 | |
Auxilium Pharmaceuticals | 0.0 | $1.6M | 59k | 27.18 | |
Rigel Pharmaceuticals (RIGL) | 0.0 | $1.9M | 482k | 3.88 | |
OraSure Technologies (OSUR) | 0.0 | $1.9M | 235k | 7.97 | |
Achillion Pharmaceuticals | 0.0 | $1.4M | 438k | 3.29 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.0 | $1.3M | 570k | 2.26 | |
Ophthotech | 0.0 | $1.3M | 37k | 35.73 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $1.8M | 59k | 30.88 | |
Achaogen | 0.0 | $1.5M | 100k | 15.46 | |
Geron Corporation (GERN) | 0.0 | $838k | 403k | 2.08 | |
Alnylam Pharmaceuticals (ALNY) | 0.0 | $779k | 12k | 67.16 | |
Amicus Therapeutics (FOLD) | 0.0 | $997k | 482k | 2.07 | |
ZIOPHARM Oncology | 0.0 | $1.1M | 245k | 4.58 | |
INC Ventrus Biosciences | 0.0 | $535k | 418k | 1.28 | |
Tesaro | 0.0 | $920k | 31k | 29.47 | |
Receptos | 0.0 | $1.0M | 24k | 41.92 | |
Acceleron Pharma | 0.0 | $992k | 29k | 34.49 | |
Uniqure Nv (QURE) | 0.0 | $477k | 31k | 15.55 | |
Salix Pharmaceuticals | 0.0 | $375k | 3.6k | 103.56 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $113k | 13k | 8.53 | |
Chemocentryx | 0.0 | $332k | 50k | 6.64 | |
Five Prime Therapeutics | 0.0 | $390k | 20k | 19.67 |